Search research articles
Contact Us
Filters
Showing results (1-10 of 214) with videos related to
Page
of 22
Sort By:
Current Pharmaceutical Biotechnology
|
March 21, 2012
Foreword: "new targets and new drugs: from in silico planning to in vivo testing"
Giovanni Maga
Future Medicinal Chemistry
|
March 1, 2019
From the magic bullet to the magic target: exploiting the diverse roles of DDX3X in viral infections and tumorigenesis
Valentina Riva, Giovanni Maga
Journal of Cell Science
|
June 28, 2003
Proliferating cell nuclear antigen (PCNA): a dancer with many partners
Giovanni Maga, Ulrich Hubscher
Current Opinion in Chemical Biology
|
September 6, 2011
DNA replication and repair bypass machines
Ulrich Hübscher, Giovanni Maga
Current Drug Metabolism
|
March 6, 2002
Combinations against combinations: associations of anti-HIV 1 reverse transcriptase drugs challenged by constellations of drug resistance mutations
Giovanni Maga, Silvio Spadari
Anti-Cancer Agents in Medicinal Chemistry
|
May 14, 2008
Repair and translesion DNA polymerases as anticancer drug targets
Giovanni Maga, Ulrich Hübscher
Current Medicinal Chemistry
|
August 22, 2006
Human terminal deoxynucleotidyl transferases as novel targets for anticancer chemotherapy
Roberto Di Santo, Giovanni Maga
Current Drug Targets. Infectious Disorders
|
February 7, 2003
Antivirals at the mirror: the lack of stereospecificity of some viral and human enzymes offers novel opportunities in antiviral drug development
Federico Focher, Silvio Spadari, Giovanni Maga
The Biochemical Journal
|
August 19, 2004
Vif is an auxiliary factor of the HIV-1 reverse transcriptase and facilitates abasic site bypass
Reynel Cancio, Silvio Spadari, Giovanni Maga
Food Chemistry
|
May 23, 2013
Cytotoxicity of α-dicarbonyl compounds submitted to in vitro simulated digestion process
Alessandra Amoroso, Giovanni Maga, Maria Daglia
Page
of 22
Search research articles
Search
Showing results (1-10 of 214) with videos related to
Sort By:
Page
of 22
Current Pharmaceutical Biotechnology
|
March 21, 2012
Foreword: "new targets and new drugs: from in silico planning to in vivo testing"
Giovanni Maga
Future Medicinal Chemistry
|
March 1, 2019
From the magic bullet to the magic target: exploiting the diverse roles of DDX3X in viral infections and tumorigenesis
Valentina Riva, Giovanni Maga
Journal of Cell Science
|
June 28, 2003
Proliferating cell nuclear antigen (PCNA): a dancer with many partners
Giovanni Maga, Ulrich Hubscher
Current Opinion in Chemical Biology
|
September 6, 2011
DNA replication and repair bypass machines
Ulrich Hübscher, Giovanni Maga
Current Drug Metabolism
|
March 6, 2002
Combinations against combinations: associations of anti-HIV 1 reverse transcriptase drugs challenged by constellations of drug resistance mutations
Giovanni Maga, Silvio Spadari
Anti-Cancer Agents in Medicinal Chemistry
|
May 14, 2008
Repair and translesion DNA polymerases as anticancer drug targets
Giovanni Maga, Ulrich Hübscher
Current Medicinal Chemistry
|
August 22, 2006
Human terminal deoxynucleotidyl transferases as novel targets for anticancer chemotherapy
Roberto Di Santo, Giovanni Maga
Current Drug Targets. Infectious Disorders
|
February 7, 2003
Antivirals at the mirror: the lack of stereospecificity of some viral and human enzymes offers novel opportunities in antiviral drug development
Federico Focher, Silvio Spadari, Giovanni Maga
The Biochemical Journal
|
August 19, 2004
Vif is an auxiliary factor of the HIV-1 reverse transcriptase and facilitates abasic site bypass
Reynel Cancio, Silvio Spadari, Giovanni Maga
Food Chemistry
|
May 23, 2013
Cytotoxicity of α-dicarbonyl compounds submitted to in vitro simulated digestion process
Alessandra Amoroso, Giovanni Maga, Maria Daglia
Page
of 22